Mode
Text Size
Log in / Sign up

Preterm Birth

Part of Obstetric Labor Complications

24 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Preterm Birth

27 trials tracked for Preterm Birth: 8 in phase 3 or 4 and 5 with published results. The most-cited published study has 824 citations.

27Trials tracked
8Phase 3 & 4
0Recruiting
5With published results
Phase distribution
Phase 4 3 Phase 3 5 Phase 2 2 Other / NA 17
  1. Phase 3 Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial Completed · 824 cited
  2. Phase 3 Confirmatory Study of 17P vs Vehicle for Prevention of Preterm Birth in Women w/ Previous Spontaneous Preterm Delivery Completed · 233 cited
  3. Phase 4 Preemie Tots: A Pilot Study to Understand the Effects of Prematurity in Toddlerhood Completed · 58 cited
  4. Phase 4 Omega Tots: A Randomized, Controlled Trial of Long-chain Polyunsaturated Fatty Acid Supplementation of Toddler Diets and Developmental Outcomes Completed · 45 cited
  5. Phase 4 Feasibility of Vaginal Progesterone to Reduce HIV-Associated Preterm Birth Completed · 5 cited
  6. Phase 3 Antenatal Micronutrient Supplementation and Infant Survival Completed
Show 21 more trials
  1. Phase 3 17OHP for Reduction of Neonatal Morbidity Due to Preterm Birth (PTB) in Twin and Triplet Pregnancies Completed
  2. Phase 3 Oral Progesterone for Prevention of Preterm Birth Completed
  3. Phase 2 Reducing Preterm Births in Underserved Pregnant Women Completed
  4. Phase 2 Efficacy Study of a Cervical Pessary Containing Progesterone for the Prevention of Preterm Delivery Completed
  5. N/A Pilot Study to Evaluate a Prototype Electronic Uterine Inhibitor to Prevent Preterm Contractions Completed
  6. N/A Prenatal Breast Pump Education of Mothers and Their Support Person Completed
  7. N/A Prevention of Preterm Birth Using Cervical Pessary in Pregnant Women With Short Cervix Completed
  8. N/A Tennessee Connections for Better Birth Outcomes Completed
  9. N/A Trial of the Use of Antenatal Corticosteroids in Developing Countries Completed
  10. N/A EngagINg the COmmunity to Reduce Preterm Birth Via Adherence To an Individualized Prematurity Prevention Plan Completed
  11. N/A Prevention of Preterm Birth With a Pessary in Singleton Gestations Completed
  12. N/A Cervix Monitor for Elasticity and Length Measurements Completed
  13. N/A Comparative Effectiveness of Treatment Options for Genital Herpes Infection to Reduce Adverse Pregnancy Outcomes Completed
  14. N/A Saving Lives at Birth: Primary Prevention of Periodontal Disease in Relation to Preterm Birth in Malawi Completed
  15. N/A Maternal Role in Oral Feed Establishment in Preterm Neonates Completed
  16. N/A Improving the Clinical Encounter to Enhance Delivery of an Individualized Prematurity Prevention Plan Completed
  17. N/A Antenatal Chlamydia Trachomatis and Neisseria Gonorrhoeae Testing to Prevent Adverse Neonatal Consequences Completed
  18. N/A A Study Evaluating Sleep, Stress and Infant Nutrition Using a Chatbot Completed
  19. N/A The Use of Progesterone to Reduce Preterm Birth Completed
  20. N/A Sustained Aeration of Infant Lungs Trial Completed
  21. N/A Happy Mother-Healthy Baby: An Anxiety-focused Early Prenatal Intervention Completed

Showing the 27 most-cited and recently-updated of 27 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

What the trials found For clinicians

Preterm Birth: what the trials found

Betamethasone administration significantly improved neonatal outcomes in cases of preterm birth, specifically reducing the number of neonates with severe respiratory complications (p < 0.001) and decreasing the number of neonates requiring immediate resuscitation after birth (p = 0.003) 4.

Hydroxyprogesterone caproate (HPC) was evaluated for its impact on preterm birth; trials recorded counts of births before 35, 32, and 37 weeks gestation 5. Additionally, 17-alpha-hydroxyprogesterone caproate was associated with lower rates of oxygen therapy at 28 days of life and fewer instances of grade 3 or 4 intraventricular hemorrhage 7.

Iron (27 mg) and folic acid (600 ug) supplementation did not show statistically significant differences in infant mortality through 6 months of age (p = 0.36), neonatal mortality (p = 0.78), or post-neonatal mortality (p = 0.11) 6.

Supplementation with Docosahexaenoic Acid and Arachidonic Acid (DHA+AA) resulted in significant changes to erythrocyte fatty acid levels (p < 0.001), though no statistically significant differences were found in infant behavior scores 2. LCPUFA oil supplementation did not show statistically significant impacts on child behavior or fatty acid levels 1.

Recent results — preliminary, needs further review

  • Xylitol gum was associated with a lower rate of preterm birth, fewer infants weighing less than 2500 grams, and fewer cases of adverse neonatal composite morbidity and mortality (all p < 0.05) 17.
  • A silicon ring (Arabin Pessary) was associated with lower rates of spontaneous delivery before 34 weeks and 28 weeks compared to the control group 20.

For the clinician treating this condition

  • Betamethasone is effective in reducing severe respiratory complications and the need for immediate resuscitation in neonates 4.
  • Progesterone-based interventions (HPC) are associated with reduced oxygen therapy requirements and lower rates of intraventricular hemorrhage 7.
  • Iron and folic acid supplementation do not significantly impact neonatal or post-neonatal mortality rates 6.

AI synthesis of 8 cited trials, updated Jun 25, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Obstetric Labor Complications

Related studies from across the Obstetric Labor Complications family.

Questions about Preterm Birth

Is there clear evidence that olfactory stimulation benefits preterm infants based on recent reviews?

No, recent systematic review finds uncertain benefit of olfactory stimulation for preterm infants; evidence is insufficient to recommend routine use.

Full answer →
What do studies say about brain development in very low birth weight preterm infants?

Very low birth weight preterm infants show slower head growth and lower IGF-1 levels in early months, and extended caffeine therapy may reduce brain-harming oxygen dips, but direct brain imaging studies are limited.

Full answer →
How do social factors and placental biology affect pregnancy complications in Black women?

Social factors like racial discrimination and socioeconomic deprivation interact with placental biology, including immune dysregulation, to increase pregnancy complication risks in Black women.

Full answer →
Will feeding my preterm baby full milk from birth lower hospital costs?

Yes, starting full milk feeds from birth may lower hospital costs for preterm infants, though it does not shorten hospital stays.

Full answer →
Do preterm children aged 0 to 2 years grow slower than full-term babies?

Yes, preterm children aged 0 to 2 years grow slower than full-term babies, especially in length, weight, and head circumference during the first months of life.

Full answer →
How does cervical length affect my risk of having another preterm birth?

A shorter cervix in mid-pregnancy strongly raises your risk of another preterm birth, and this risk is partly inherited and linked to your history.

Full answer →
See all 6 questions about Preterm Birth →

All Preterm Birth Articles